Ajanta Pharma reports 55% fall in Q3 consolidated net profit

31 Jan 2019 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2018.

The company has reported a fall of 42% in its net profit at Rs 95.47 crore for the quarter under review as compared to Rs 164.59 crore for the same quarter in the previous year. Total income of the company decreased by 17.80% at Rs 464.82 crore for Q3FY19 as compared Rs 565.47 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 54.63% in its net profit at Rs 66.90 crore for the quarter under review as compared to Rs 147.47 crore for the same quarter in the previous year. Total income of the company decreased by 18.71% at Rs 489.52 crore for Q3FY19 as compared Rs 602.20 crore for the corresponding quarter previous year.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×